Indicated for skeletally immature patients undergoing limb-salvage near a growth plate (e.g., distal femur/proximal tibia). Designs: minimally invasive magnetically driven expanders vs older surgical-lengthening types. Aims to maintain limb length equality during growth while preserving function and oncologic safety. Complications: infection, mechanical failure, soft-tissue problems, stiffness; multiple lengthenings required. Requires multidisciplinary follow-up through growth until maturity.
Indicated for skeletally immature patients undergoing limb-salvage near a growth plate (e.g., distal femur/proximal tibia). Designs: minimally invasive magnetically driven expanders vs older surgical-lengthening types. Aims to maintain limb length equality during growth while preserving function and oncologic safety. Complications: infection, mechanical failure, soft-tissue problems, stiffness; multiple lengthenings required. Requires multidisciplinary follow-up through growth until maturity.
What is the primary indication for using an expandable prosthesis in paediatric oncology?
Which of the following is a common complication associated with expandable prostheses?
What is a significant advantage of non-invasive electromagnetic (NIE) expandable prostheses over surgical-lengthening types?
What is the minimum predicted leg length discrepancy (LLD) threshold that generally indicates the need for an expandable prosthesis?
In which anatomical location are expandable prostheses most commonly indicated?
Which of the following statements best reflects the historical development of expandable prostheses?
Why is multidisciplinary follow-up important for patients with expandable prostheses?
What is a disadvantage of conventional (surgical) expandable prostheses?
What is the primary goal of using an expandable prosthesis in paediatric limb salvage surgery?
What is the most common primary malignant bone tumor in children?
